Recently into his role as Chief Medical Officer (CMO) at Health Innovation Oxford & Thames Valley, that is the question Ryan Kerstein has been asked most, by consultants and by company founders. It was something, Ryan admits, he did not have a working answer until he was inside it.
The short version. There are 15 Health Innovation Networks, commissioned by NHS England and the Office for Life Sciences. Research proves something works and providers run services; the gap between those two, where something has been shown to work and still has not reached the patients it was built for, is where, he adds, the HINs do their work.
He continues that it is worth being clear about the limits. A HIN does not commission and cannot make any trust adopt anything. What it has is health economists who can size a problem and put a value on solving it, teams running the national patient safety programmes every provider is expected to deliver, a triaged front door for industry so start-ups do not land raw in a clinical director’s inbox, and the standing to convene across organisations without owning any of them. That last one is key. If you are a clinician with an idea and no route to test it, an ICB director who needs an independent view on a technology, or a company trying to work with the NHS, there is a door for you.
In the first of his CMO blog posts, Ryan has written up which door is which, with a short series to follow on how each of them works in practice. Read more.
The Health Innovation Oxford & Thames Valley are active members of the Thames Valley Chambers Thames Valley Health and Life Sciences working group. Find out more and look to register for future events here, here and here.

